Table 1.
Anthropometric and clinical characteristics.
| T2D patients | Healthy group | p | |
|---|---|---|---|
| n | 29 | 25 | |
| Female, n (%) | 18 (42) | 16 (44) | >0.9999χ |
| Male, n (%) | 11 (38) | 9 (36) | |
| Age, n | 57 (±12.3) | 50 (±9.0) | 0.0299‡ |
| Weight, kg | 80.0 (±15.2) | 70.3 (±14.3) | 0.0274‡ |
| BMI, kg/m2 | 30.1 (±5.4) | 27.1 (±4.7) | 0.0057‡ |
| Glucose, mg/dL | 161.0 (±60.01) | 86.86 (±8.71) | <0.0001‡ |
| HbA1c, % | 8.68 (±1.77) | 5.75 (±0.31) | <0.0001‡ |
| Controlled HbA1c < 7, n (%) | 6 (17.6) | – | - |
| Non-controlled HbA1c > 7, n (%) | 23 (82.3) | – | - |
| Normoweight, n (%) | 3 (10) | 11 (44) | 0.0182χ |
| Overweight, n (%) | 8 (28) | 5 (20) | |
| Obesity, n (%) | 18 (62) | 9 (36) | |
| Non-obese (% body fat), n (%) | 8 (28) | 7 (28) | 0.4501χ |
| Obese (% body fat), n (%) | 21 (72) | 18 (72) | |
| Metabolic syndrome, n (%) | 24 (83) | 0 (0) | - |
| Total Cholesterol, mg/dL | 166.2 (±44.33) | 190.0 (±36.05) | 0.0168† |
| HDL Cholesterol, mg/dL | 39.20 (±13.88) | 49.26 (±17.27) | 0.0111† |
| LDL Cholesterol, mg/dL | 105.0 (±96.19) | 112.4 (±26.93) | 0.0077† |
| Triglycerides, mg/dL | 247.3 (±135.5) | 155.9 (±83.85) | 0.0137‡ |
| Atherogenic index, Total-Chol/HDL-Chol | 4.44 (±1.19) | 4.29 (±1.24) | 0.7147‡ |
| Serum urea, mg/dL | 38.93 (±23.89) | 55.05 (±48.65) | 0.5237† |
| Serum creatinine, mg/dL | 0.975 (±0.85) | 0.829 (±0.20) | 0.5654‡ |
Values are represented as mean (standard deviation). T2D, Type 2 Diabetes; BMI, Body Mass Index; HbA1c, Glycosylated hemoglobin. †U Mann-Whitney, ‡ Unpaired t-test. Χ Chi-Square (Fisher's exact) test.